Instrument Business Outlook Volume 33 - Issue 21

18 Feb 2025

Categories:

Instrument Business Outlook

Table of Contents

Survey of Scientists Shows Already Tough Budget Situation Prior to NIH Announcement
- January Survey Results
- Survey Participants
PE/VC Investment Activity Improves in 2024
- Top Deals
- Top Technologies
Executive Briefing
- BD to Separate Biosciences Business
- Bio-Rad Announces Acquisition and Restructuring
- 10x Litigation Update and Settlement
- VION Buys Assay Supplier
Fourth Quarter Results: Bio-Techne, Illumina and Shimadzu AMI
- Bio-Techne Anticipates Positive Growth for Fiscal 2025
  - Products
  - Divisions
  - End-Markets
  - Geography
  - Guidance
- Illumina Predicts Mixed Results for 2025
  - Q4
  - FYE
- Shimadzu Post Solid MS Sales
  - Product Lines
  - End-Markets
  - Geography
  - Orders
  - Guidance
Market Profile: Laboratory Digestion
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Biopharma: Cell and Gene Therapy Update
- Semiconductor & Chemicals: PFAS in Wastewater
- Energy: Battery Innovations
Region Watch
- China: Clinical Trials Advantages
- EU: Sequencing and Foodborne Outbreaks
- South Korea: New University Support Planned
News
- Life Science Instruments
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
- Informatics
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Bioprocess Analysis
  - Company Announcements
  - Product Introductions
- Process Analysis
  - Company Announcements
  - Product Introductions
- Materials Characterization
  - Company Announcements
  - Product Introductions
Bottom Line